In a study on the impact of EMT on glycogene expression in pancreatic cancer cells treated with TGF-β and in panels of pancreatic cell lines exhibiting either epithelial or mesenchymal morphology, it was found that the mesenchymal condition was associated with increased proteoglycan biosynthesis [21] and that some glycosyltransferases displayed differential expression in mesenchymal-like cells [21]. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.